Novel Para-Phenylenediamine-Based Derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization

被引：0

作者：

Smaldone, Gerardina ^{[1
]}

Miranda, Maria Rosaria ^{[1
]}

Di Matteo, Francesca ^{[1
]}

Napolitano, Valeria ^{[1
]}

Aliberti, Michela ^{[1
]}

Musella, Simona ^{[1
]}

Di Sarno, Veronica ^{[1
]}

Lauro, Gianluigi ^{[1
]}

Bifulco, Giuseppe ^{[1
]}

Pepe, Giacomo ^{[1
]}

Aquino, Giovanna ^{[1
]}

Tecce, Mario Felice ^{[1
]}

Gomez-Monterrey, Isabel Maria ^{[2
]}

Campiglia, Pietro ^{[1
]}

Ostacolo, Carmine ^{[1
]}

Bertamino, Alessia ^{[1
]}

Vestuto, Vincenzo ^{[1
]}

Ciaglia, Tania ^{[1
]}

机构：

[1] Univ Salerno, Dept Pharm, Via G Paolo II 132, I-84084 Salerno, Italy

[2] Univ Federico II Naples, Dept Pharm, Via D Montesano 49, I-80131 Naples, Italy

来源：

CHEMMEDCHEM | 2025年 / 20卷 / 14期

关键词：

binding assays; cytotoxic effects; kinase inhibitors; novel chemotypes; synthesis; ACCURATE DOCKING; PSEUDOKINASE; PROTEIN; GLIDE; TARGET;

D O I：

10.1002/cmdc.202500247

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

ROR1 kinase is an underexplored promising target for the development of novel anticancer drugs, being strongly expressed in several cancer cell lines, but poorly in non-tumor cells. This property, together with the scarce number of molecules effective against ROR1, leads to the design and development of a research program aimed at the discovery of new chemical entities able to inhibit ROR1 thus interfering with its protumoral activity. Step-by-step in silico studies guide the design and synthesis of para-phenylenediamine-based compounds. Surface plasmon resonance and Cellular Thermal Shift Assay analyses, coordinated with cytotoxicity assays carried out on JeKo-1 (mantle cell lymphoma) and SH-SY5Y (neuroblastoma cell) cell lines, demonstrate the strong affinity and the anticancer potential of the derivative 17, respectively, further confirming its mechanism of action. Moreover, pharmacokinetic assessment reveals a good stability profile for derivative 17, paving the way for additional SAR studies on the para-phenylenediamine as a scaffold for developing new ROR1 inhibitors.

引用

页数：15

共 46 条

[21] Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening [J].

Halgren, TA ;

Murphy, RB ;

Friesner, RA ;

Beard, HS ;

Frye, LL ;

Pollard, WT ;

Banks, JL .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1750-1759

[22] ROR1 and ROR2 play distinct and opposing roles in endometrial cancer [J].

Henry, C. E. ;

Llamosas, E. ;

Daniels, B. ;

Coopes, A. ;

Tang, K. ;

Ford, C. E. .

GYNECOLOGIC ONCOLOGY, 2018, 148 (03) :576-584

[23] Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer [J].

Henry, C. E. ;

Llamosas, E. ;

Djordjevic, A. ;

Hacker, N. F. ;

Ford, C. E. .

ONCOGENESIS, 2016, 5 :e226-e226

[24] First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells [J].

Hojjat-Farsangi, M. ;

Daneshmanesh, A. H. ;

Khan, A. S. ;

Shetye, J. ;

Mozaffari, F. ;

Kharaziha, P. ;

Rathje, L-S ;

Kokhaei, P. ;

Hansson, L. ;

Vagberg, J. ;

Bystrom, S. ;

Olsson, E. ;

Lofberg, C. ;

Norstrom, C. ;

Schultz, J. ;

Norin, M. ;

Olin, T. ;

Osterborg, A. ;

Mellstedt, H. ;

Moshfegh, A. .

LEUKEMIA, 2018, 32 (10) :2291-2295

[25]

Hojjat-Farsangi M, 2021, HANDB EXP PHARMACOL, V269, P75, DOI 10.1007/164_2021_535

[26] In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel [J].

Iraci, Nunzio ;

Carotenuto, Lidia ;

Ciaglia, Tania ;

Belperio, Giorgio ;

Di Matteo, Francesca ;

Mosca, Ilaria ;

Carleo, Giusy ;

Basilicata, Manuela Giovanna ;

Ambrosino, Paolo ;

Turcio, Rita ;

Puzo, Deborah ;

Pepe, Giacomo ;

Gomez-Monterrey, Isabel ;

Soldovieri, Maria Virginia ;

Di Sarno, Veronica ;

Campiglia, Pietro ;

Miceli, Francesco ;

Bertamino, Alessia ;

Ostacolo, Carmine ;

Taglialatela, Maurizio .

JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) :9124-9149

[27] The cellular thermal shift assay for evaluating drug target interactions in cells [J].

Jafari, Rozbeh ;

Almqvist, Helena ;

Axelsson, Hanna ;

Ignatushchenko, Marina ;

Lundback, Thomas ;

Nordlund, Par ;

Molina, Daniel Martinez .

NATURE PROTOCOLS, 2014, 9 (09) :2100-2122

[28] A ROR1 HER3 IncRNA signalling axis modulates the Hippo YAP pathway to regulate bone metastasis [J].

Li, Chunlai ;

Wang, Shouyu ;

Xing, Zhen ;

Lin, Aifu ;

Liang, Ke ;

Song, Jian ;

Hui, Qingsong ;

Yao, Jun ;

Chen, Zhongyuan ;

Park, Peter K. ;

Hawke, David H. ;

Zhou, Jianwei ;

Zhou, Yan ;

Zhang, Shuxing ;

Liang, Han ;

Hung, Mien-Chie ;

Gallick, Gary E. ;

Han, Leng ;

Lin, Chunru ;

Yang, Liuqing .

NATURE CELL BIOLOGY, 2017, 19 (02) :106-119

[29] The Impact of Imputation on Meta-Analysis of Genome-Wide Association Studies [J].

Li, Jian ;

Guo, Yan-fang ;

Pei, Yufang ;

Deng, Hong-Wen .

PLOS ONE, 2012, 7 (04)

[30]

Liu J., 2022, SIGNAL TRANSDUCT TAR, V7

← 1 2 3 4 5 →